Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China flag China · Delayed Price · Currency is CNY
46.40
-0.25 (-0.54%)
At close: Mar 2, 2026
39.30%
Market Cap 51.47B
Revenue (ttm) 4.27B
Net Income (ttm) 308.94M
Shares Out 1.11B
EPS (ttm) 0.27
PE Ratio 169.68
Forward PE 98.72
Dividend 0.42 (0.89%)
Ex-Dividend Date n/a
Volume 2,203,934
Average Volume 2,795,779
Open 46.50
Previous Close 46.65
Day's Range 46.20 - 47.47
52-Week Range 32.63 - 62.65
Beta -0.07
RSI 30.89
Earnings Date Apr 13, 2026

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. The company offers pharmaceutical products in the areas of anesthesia and analgesia, diabetes mellitus and complications, tumor, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory, narcotic analgesics, endocrine system, enteral parenteral, nutrition, neuropsychiatric, cardiovascular, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 5,337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002653
Full Company Profile

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.

Financial Statements

News

There is no news available yet.